NASDAQ:AKRO

Akero Therapeutics Earning Date

USA |NASDAQ |USD

AKRO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.91 $-0.83 $-0.63
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $0.00 $0.00

Akero Therapeutics's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

AKRO Earnings Date & History Chart

AKRO Earnings & Revenue Forecast

AKRO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.09 $-1.59 $-0.79
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-3.11 $-3.56 $-2.80
Dec 2022 6 $-3.69 $-4.46 $-3.22

AKRO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.11 $-1.11 $-1.11
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.15 $-3.13 $-3.13
Dec 2022 0 / 0 $-3.63 $-3.49 $-3.49

AKRO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $0.00 $0.00 $0.00
Dec 2022 6 $0.00 $0.00 $0.00

AKRO Earnings Date & Revenue History

AKRO Earnings History

|
Show More
Show More

AKRO Revenue History

|
Show More
Show More

Akero Therapeutics Next Earnings Date & Report

AKRO Next Earnings Date & Report Preview: Sep 2021 (FQ)

AKRO's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Akero Therapeutics's next quarterly earnings is $-0.91, with a low EPS estimation of $-1.15, and a high estimation of $-0.75.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.92, the last 2 month trend is $-0.83, and the 3 month trend is $-0.83.

Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Akero Therapeutics Previous Earnings Dates & Reports

AKRO Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Akero Therapeutics's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.

AKRO's earnings per share (EPS) was $-0.83, missing the consensus analysts forecast of $-0.71 by -17.61%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 93.02%, and lower than the same period a year before (Jun 2020) by 45.61%.

Revenues were $0.00.

The company reported a net income of $-28.93M.

Free cash flow for the quarter was $-20.03M , compared to $-18.35M last quarter and $-22.58M a year before.

AKRO ended the quarter with $1.64M in total debt, a decrease of -8.87% compared to the previous quarter.

AKRO Previous Earnings Date & Report Recap: Dec 2020 (FY)

Akero Therapeutics's previous annual earnings date was Mar 16, 2021 for its fiscal year ended Dec 31, 2020.

AKRO's earnings per share (EPS) was $-2.48, missing the consensus analysts forecast of $-2.21 by 12.22% , and lower than the previous year's EPS (Dec 2019) by 81.02%.

Revenues were $0.00.

The company reported a net income of $-79.21M.

Akero Therapeutics reported a free cash flow of $-70.95M for its fiscal year, compared to $-35.63M a year ago.

The company ended the fiscal year with $1.81M in total debt. lala